Wilson G J, Robertson J M, Walters F J, Steward D J, MacGregor D C
Ann Thorac Surg. 1980 Nov;30(5):472-81. doi: 10.1016/s0003-4975(10)61300-8.
Using an intramyocardial pH needle probe (21 gauge) to monitor myocardial metabolism during ischemia, we determined the effect of potassium cardioplegia at both moderate and deep hypothermia. Five groups of 5 dogs each were placed on cardiopulmonary bypass and the pH probe was inserted approximately 10 mm into the left ventricular free wall. Cardiac ischemia was achieved by cross-clamping the ascending aorta at 37 degrees C (Group 1), 27 degrees C (Group 2), or 17 degrees C (Group 3). In the remaining two groups, aortic cross-clamping was followed by the infusion of 600 to 800 ml of potassium cardioplegic solution adjusted to cardiac temperatures of 27 degrees C (Group 4) or 17 degrees C (Group 5). In each group, myocardial temperature was maintained constant, electrical and mechanical activity observed, and pH recorded until a plateau was reached or for 3 hours. Our results show a progressive and significant decrease in the metabolic rate with reduction in temperature over the 37 degrees to 17 degrees C range. By abolishing contractile activity, potassium cardioplegia markedly reduces the rate of hydrogen ion accumulation at 27 degrees C, but at 17 degrees C the additive effect of cardioplegia is much less pronounced. These observations support the principle of reducing contractile activity to a minimum during elective arrest of the heart but indicate that potassium cardioplegia does little to further reduce the rate of anaerobic metabolism, as shown by the measurement of intramyocardial pH, under conditions of deep hypothermia.
我们使用心肌内pH针式探头(21号)监测缺血期间的心肌代谢,确定了中度和深度低温下钾停搏液的作用。将五组实验对象,每组5只狗置于体外循环,将pH探头插入左心室游离壁约10毫米处。通过在37℃(第1组)、27℃(第2组)或17℃(第3组)交叉夹闭升主动脉来实现心脏缺血。在其余两组中,交叉夹闭主动脉后,输注600至800毫升调整至心脏温度为27℃(第4组)或17℃(第5组)的钾停搏液。在每组中,保持心肌温度恒定,观察电活动和机械活动,并记录pH值,直到达到平台期或持续3小时。我们的结果表明,在37℃至17℃范围内,随着温度降低,代谢率逐渐显著下降。通过消除收缩活动,钾停搏液在27℃时显著降低氢离子积累速率,但在17℃时,停搏液的附加作用不太明显。这些观察结果支持在心脏选择性停搏期间将收缩活动降至最低的原则,但表明在深度低温条件下,如通过心肌内pH测量所示,钾停搏液对进一步降低无氧代谢速率作用不大。